Evidence map›Paper›PMID 20562257›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5.

Usman Ahmad, Rahmat Ali, Amir H Lebastchi, Lingfeng Qin, Sheng-fu L Lo, Alexander O Yakimov, Salman F Khan, Jonathan C Choy, Arnar Geirsson, Jordan S Pober and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2011
    Article
  11. Toll in the vessel wall--for better or worse?Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  12. Unexpected protective role for Toll-like receptor 3 in the arterial wall.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Usman AhmadDepartment of Surgery, Yale University School of Medicine, New Haven, CT 06510, USA.
Rahmat Ali
Amir H Lebastchi
Lingfeng Qin
Sheng-fu L Lo
Alexander O Yakimov
Salman F Khan
Jonathan C Choy
Arnar Geirsson
Jordan S Pober
George Tellides
Yale University · USVA Connecticut Healthcare System · US

Funding

SOCS-1 and endothelial dysfunction in graft arteriosclerosisP01HL070295 · NHLBI · YALE UNIVERSITY · PI POBER, JORDAN S · 2001 to 2010
$17.9M
NHLBI NIH HHS P01 HL070295NHLBI NIH HHS P01 HL70295
6 · The paper itself

Abstract

Atherosclerosis of native coronary arteries and graft arteriosclerosis in transplanted hearts are characterized by activation of innate and adaptive immune responses. Nucleic acids generated by infections or cell death have been detected within arteriosclerotic lesions, and it is known that microbial and synthetic nucleic acids evoke inflammatory responses in cultured vascular cells. In this study, we report that model RNA, but not DNA, instigated robust cytokine and chemokine production from intact human coronary arteries containing both intrinsic vascular cells and resident/infiltrating leukocytes. An ssRNA analog induced TNF-alpha and IFN-gamma-induced protein of 10 kDa secretion by isolated human PBMCs, but not vascular cells. Conversely, synthetic dsRNA induced these inflammatory mediators by vascular cells, but not PBMCs. IFN-gamma, a cytokine linked to atherosclerosis and graft arteriosclerosis, potentiated the inflammatory responses of intact arteries and cultured vascular smooth muscle cells (VSMCs) to polyinosinic:polycytidylic acid [poly(I:C)] and was necessary for inflammatory responses of VSMC to self-RNA derived from autologous cells. IFN-gamma also induced the expression of TLR3, melanoma differentiation-associated gene 5, and retinoic acid-inducible gene I dsRNA receptors. Small interfering RNA knockdown revealed that TLR3 mediated VSMC activation by poly(I:C), whereas melanoma differentiation-associated gene 5 was more important for VSMC stimulation by self-RNA. IFN-gamma-mediated induction of dsRNA receptors and priming for inflammatory responses to poly(I:C) was confirmed in vivo using immunodeficient mice bearing human coronary artery grafts. These findings suggest that IFN-gamma, and by inference adaptive immunity, sensitizes the vasculature to innate immune activators, such as RNA, and activation of IFN-gamma-primed vascular cells by exogenous or endogenous sources of RNA may contribute to the inflammatory milieu of arteriosclerosis.

Indexed as

AnimalsCells, CulturedChemokine CXCL10Coronary VesselsDEAD-box RNA HelicasesEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoblottingInterferon-gammaInterferon-Induced Helicase, IFIH1In Vitro TechniquesMiceMice, SCIDMuscle, Smooth, VascularMyocytes, Smooth MuscleChemokine CXCL10DEAD-box RNA HelicasesIFIH1 protein, humanInterferon-gammaInterferon-Induced Helicase, IFIH1Poly I-CRNA, Double-StrandedToll-Like Receptor 2Tumor Necrosis Factor-alpha

Identifiers

PMID20562257
PMCPMC2902797
OpenAlexW2170476119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.